Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization

Genes and Development

Volumn 21, Issue 12, 2007, Pages 1546-1558

  Nolan, Daniel J ^a,c   Ciarrocchi, Alessia ^b   Mellick, Albert S ^a   Jaggi, Jaspreet S ^b   Bambino, Kathryn ^a   Gupta, Sunita ^a   Heikamp, Emily ^a   McDevitt, Michael R ^b   Scheinberg, David A ^b   Benezra, Robert ^b   Mittal, Vivek ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Bone marrow transplantation; Endothelial cells; Endothelial progenitor cells; Neovascularization; Tumor angiogenesis; VE cadherin

Indexed keywords

ARTICLE; BONE MARROW; BREAST TUMOR; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENETIC MARKER; IN VIVO STUDY; MICROSCOPY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; STEM CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIETIC STEM CELLS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34250719709     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.436307     Document Type: Article

References (57)

1. Aozuka, Y., Koizumi, K., Saitoh, Y., Ueda, Y., Sakurai, H., and Saiki, I. 2004. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice. Cancer Lett. 216: 35-42.
2. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J.M. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
3. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., and Isner, J.M. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18: 3964-3972.
4. Baumann, C.I., Bailey, A.S., Li, W., Ferkowicz, M.J., Yoder, M.C., and Fleming, W.H. 2004. PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythroid progenitors. Blood 104: 1010-1016.
5. Bertolini, F., Shaked, Y., Mancuso, P., and Kerbel, R.S. 2006. The multifaceted circulating endothelial cell in cancer: Towards marker and target identification. Nat. Rev. Cancer 6: 835-845.
6. Borchardt, P.E., Yuan, R.R., Miederer, M., McDevitt, M.R., and Scheinberg, D.A. 2003. Targeted actinium-225 in vivo generators for therapy of ovarian cancer. Cancer Res. 63: 5084-5090.
7. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature 438: 932-936.
8. Carmeliet, P. and Jain, R.K. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
9. Conejo-Garcia, J.R., Buckanovich, R.J., Benencia, F., Courreges, M.C., Rubin, S.C., Carroll, R.G., and Coukos, G. 2005. Vascular leukocytes contribute to tumor vascularization. Blood 105: 679-681.
10. Cook-Mills, J.M., Gallagher, J.S., and Feldbush, T.L. 1996. Isolation and characterization of high endothelial cell lines derived from mouse lymph nodes. In Vitro Cell. Dev. Biol. Anim. 32: 167-177.
11. Coussens, L.M. and Werb, Z. 2002. Inflammation and cancer. Nature 420: 860-867.
12. Crosby, C.V., Fleming, P.A., Argraves, W.S., Corada, M., Zanetta, L., Dejana, E., and Drake, C.J. 2005. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105: 2771-2776.
13. De Palma, M., Venneri, M.A., Roca, C., and Naldini, L. 2003. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9: 789-795.
14. De Palma, M., Venneri, M.A., Galli, R., Sergi, L.S., Politi, L.S., Sampaolesi, M., and Naldini, L. 2005. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226.
15. Desai, K.V., Xiao, N., Wang, W., Gangi, L., Greene, J., Powell, J.I., Dickson, R., Furth, P., Hunter, K., Kucherlapati, R., et al. 2002. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc. Natl. Acad. Sci. 99: 6967-6972.
16. Duda, D.G., Cohen, K.S., Kozin, S.V., Perentes, J.Y., Fukumura, D., Scadden, D.T., and Jain, R.K. 2006. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 107: 2774-2776.
17. Folkman, J. 1971. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285: 1182-1186.
18. Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. 2003. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159.
19. Gothert, J.R., Gustin, S.E., van Eekelen, J.A., Schmidt, U., Hall, M.A., Jane, S.M., Green, A.R., Gottgens, B., Izon, D.J., and Begley, C.G. 2004. Genetically tagging endothelial cells in vivo: Bone marrow-derived cells do not contribute to tumor endothelium. Blood 104: 1769-1777.
20. Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., and Keshet, E. 2006. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 124: 175-189.
21. Guy, C.T., Cardiff, R.D., and Muller, W.J. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12: 954-961.
22. Hanahan, D. and Folkman, J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
23. He, Y., Rajantie, I., Ilmonen, M., Makinen, T., Karkkainen, M.J., Haiko, P., Salven, P., and Alitalo, K. 2004. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res. 64: 3737-3740.
24. Khakoo, A.Y. and Finkel, T. 2005. Endothelial progenitor cells. Annu. Rev. Med. 56: 79-101.
25. Kim, I., Yilmaz, O.H., and Morrison, S.J. 2005. CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells. Blood 106: 903-905.
26. Kopp, H.G., Ramos, C.A., and Rafii, S. 2006. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol. 13: 175-181.
27. Laitinen, L., Virtanen, I., and Saxen, L. 1987. Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates. J. Histochem. Cytochem. 35: 55-65.
28. Lampugnani, M.G., Orsenigo, F., Gagliani, M.C., Tacchetti, C., and Dejana, E. 2006. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J. Cell Biol. 174: 593-604.
29. Lamszus, K., Brockmann, M.A., Eckerich, C., Bohlen, P., May, C., Mangold, U., Fillbrandt, R., and Westphal, M. 2005. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin. Clin. Cancer Res. 11: 4934-4940.
30. Larrivee, B., Niessen, K., Pollet, I., Corbel, S.Y., Long, M., Rossi, F.M., Olive, P.L., and Karsan, A. 2005. Minimal contribution of marrow-derived endothelial precursors to tumor vasculature. J. Immunol. 175: 2890-2899.
31. Li, H., Gerald, W.L., and Benezra, R. 2004. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade. Cancer Res. 64: 6137-6143.
32. Liao, F., Doody, J.F., Overholser, J., Finnerty, B., Bassi, R., Wu, Y., Dejana, E., Kussie, P., Bohlen, P., and Hicklin, D.J. 2002. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res. 62: 2567-2575.
33. Lin, E.Y., Nguyen, A.V., Russell, R.G., and Pollard, J.W. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193: 727-740.
34. Lin, E.Y., Jones, J.G., Li, P., Zhu, L., Whitney, K.D., Muller, W.J., and Pollard, J.W. 2003. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163: 2113-2126.
35. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7: 1194-1201.
36. Machein, M.R., Renninger, S., de Lima-Hahn, E., and Plate, K.H. 2003. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol. 13: 582-597.
37. May, C., Doody, J.F., Abdullah, R., Balderes, P., Xu, X., Chen, C.P., Zhu, Z., Shapiro, L., Kussie, P., Hicklin, D.J., et al. 2005. Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 105: 4337-4344.
38. McDevitt, M.R., Ma, D., Lai, L.T., Simon, J., Borchardt, P., Frank, R.K., Wu, K., Pellegrini, V., Curcio, M.J., Miederer, M., et al. 2001. Tumor therapy with targeted atomic nanogenerators. Science 294: 1537-1540.
39. 225Ac radioimmunopharmaceuticals. Appl. Radiat. Isot. 57: 841-847.
40. Minami, E., Laflamme, M.A., Saffitz, J.E., and Murry, C.E. 2005. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112: 2951-2958.
41. Nozawa, H., Chiu, C., and Hanahan, D. 2006. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. 103: 12493-12498.
42. + cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
43. Perfetto, S.P., Chattopadhyay, P.K., and Roederer, M. 2004. Seventeen-colour flow cytometry: Unravelling the immune system. Nat. Rev. Immunol. 4: 648-655.
44. Peters, B.A., Diaz, L.A., Polyak, K., Meszler, L., Romans, K., Guinan, E.C., Antin, J.H., Myerson, D., Hamilton, S.R., Vogelstein, B., et al. 2005. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat. Med. 11: 261-262.
45. Pollard, J.W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4: 71-78.
46. Rafii, S., Lyden, D., Benezra, R., Hattori, K., and Heissig, B. 2002. Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat. Rev. Cancer 2: 826-835.
47. Rajantie, I., Ilmonen, M., Alminaite, A., Ozerdem, U., Alitalo, K., and Salven, P. 2004. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104: 2084-2086.
48. Ribatti, D. 2004. The involvement of endothelial progenitor cells in tumor angiogenesis. J. Cell. Mol. Med. 8: 294-300.
49. Ruzinova, M.B., Schoer, R.A., Gerald, W., Egan, J.E., Pandolfi, P.P., Rafii, S., Manova, K., Mittal, V., and Benezra, R. 2003. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4: 277-289.
50. Shaked, Y., Ciarrocchi, A., Franco, M., Lee, C.R., Man, S., Cheung, A.M., Hicklin, D.J., Chaplin, D., Foster, F.S., Benezra, R., et al. 2006. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313: 1785-1787.
51. + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 7: 870-879.
52. Spring, H., Schuler, T., Arnold, B., Hammerling, G.J., and Ganss, R. 2005. Chemokines direct endothelial progenitors into tumor neovessels. Proc. Natl. Acad. Sci. 102: 18111-18116.
53. Tudor, K.S., Deem, T.L., and Cook-Mills, J.M. 2000. Novel α 4-integrin ligands on an endothelial cell line. Biochem. Cell Biol. 78: 99-113.
54. Urbich, C. and Dimmeler, S. 2004. Endothelial progenitor cells functional characterization. Trends Cardiovasc. Med. 14: 318-322.
55. Voswinckel, R., Ziegelhoeffer, T., Heil, M., Kostin, S., Breier, G., Mehling, T., Haberberger, R., Clauss, M., Gaumann, A., Schaper, W., et al. 2003. Circulating vascular progenitor cells do not contribute to compensatory lung growth. Circ. Res. 93: 372-379.
56. Xiao, K., Allison, D.F., Kottke, M.D., Summers, S., Sorescu, G.P., Faundez, V., and Kowalczyk, A.P. 2003. Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells. J. Biol. Chem. 278: 19199-19208.
57. Ziegelhoeffer, T., Fernandez, B., Kostin, S., Heil, M., Voswinckel, R., Helisch, A., and Schaper, W. 2004. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94: 230-238.